$PBH
Prestige Consumer Healthcare Inc

2021 Q2 Form 10-Q Financial Statement

#000129594721000029 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $269.2M $229.4M
YoY Change 17.34% -1.19%
Cost Of Revenue $110.2M $95.53M
YoY Change 15.33% -2.61%
Gross Profit $159.0M $133.9M
YoY Change 18.78% -0.15%
Gross Profit Margin 59.07% 58.36%
Selling, General & Admin $61.91M $47.70M
YoY Change 29.79% -15.58%
% of Gross Profit 38.93% 35.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.594M $7.467M
YoY Change 1.7% 5.75%
% of Gross Profit 4.78% 5.58%
Operating Expenses $67.67M $53.75M
YoY Change 25.9% -14.11%
Operating Profit $91.34M $80.12M
YoY Change 14.01% 12.08%
Interest Expense -$15.08M -$21.90M
YoY Change -31.16% -12.4%
% of Operating Profit -16.51% -27.33%
Other Income/Expense, Net $105.0K -$10.00K
YoY Change -1150.0% -97.6%
Pretax Income $76.37M $58.20M
YoY Change 31.22% 26.38%
Income Tax $18.62M $14.46M
% Of Pretax Income 24.37% 24.85%
Net Earnings $57.76M $43.71M
YoY Change 32.14% 28.83%
Net Earnings / Revenue 21.46% 19.05%
Basic Earnings Per Share $1.15 $0.87
Diluted Earnings Per Share $1.14 $0.86
COMMON SHARES
Basic Shares Outstanding 50.14M shares 50.26M shares
Diluted Shares Outstanding 50.67M shares 50.81M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $163.6M $57.90M
YoY Change 182.6% 99.66%
Cash & Equivalents $163.6M $57.94M
Short-Term Investments
Other Short-Term Assets $9.008M $8.500M
YoY Change 5.98% -7.61%
Inventory $105.5M $116.8M
Prepaid Expenses
Receivables $130.3M $112.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $408.5M $295.6M
YoY Change 38.22% -4.82%
LONG-TERM ASSETS
Property, Plant & Equipment $69.83M $58.33M
YoY Change 19.72% 13.5%
Goodwill $577.8M $577.1M
YoY Change 0.12% -0.2%
Intangibles $2.470B $2.483B
YoY Change -0.54% -0.73%
Long-Term Investments
YoY Change
Other Assets $2.522M $2.903M
YoY Change -13.12% -4.44%
Total Long-Term Assets $3.151B $3.155B
YoY Change -0.13% 0.14%
TOTAL ASSETS
Total Short-Term Assets $408.5M $295.6M
Total Long-Term Assets $3.151B $3.155B
Total Assets $3.559B $3.450B
YoY Change 3.16% -0.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.96M $32.35M
YoY Change -4.29% -47.91%
Accrued Expenses $83.70M $88.70M
YoY Change -5.63% 17.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.607M $1.200M
YoY Change 117.25%
Total Short-Term Liabilities $125.0M $131.9M
YoY Change -5.22% -8.06%
LONG-TERM LIABILITIES
Long-Term Debt $1.545B $1.621B
YoY Change -4.65% -8.92%
Other Long-Term Liabilities $8.555M $25.26M
YoY Change -66.13% 26.66%
Total Long-Term Liabilities $1.554B $1.646B
YoY Change -5.59% -8.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $125.0M $131.9M
Total Long-Term Liabilities $1.554B $1.646B
Total Liabilities $2.143B $2.223B
YoY Change -3.61% -5.76%
SHAREHOLDERS EQUITY
Retained Earnings $1.067B $887.8M
YoY Change 20.13% 20.67%
Common Stock $542.0K $539.0K
YoY Change 0.56% 0.37%
Preferred Stock
YoY Change
Treasury Stock (at cost) $133.6M $118.9M
YoY Change 12.44% 32.82%
Treasury Stock Shares 4.151M shares 3.750M shares
Shareholders Equity $1.416B $1.227B
YoY Change
Total Liabilities & Shareholders Equity $3.559B $3.450B
YoY Change 3.16% -0.31%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $57.76M $43.71M
YoY Change 32.14% 28.83%
Depreciation, Depletion And Amortization $7.594M $7.467M
YoY Change 1.7% 5.75%
Cash From Operating Activities $69.31M $75.15M
YoY Change -7.78% 42.4%
INVESTING ACTIVITIES
Capital Expenditures $1.500M $2.553M
YoY Change -41.25% 30.52%
Acquisitions
YoY Change
Other Investing Activities -$177.0K $0.00
YoY Change
Cash From Investing Activities -$1.323M -$2.553M
YoY Change -48.18% 30.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $63.65M -$111.4M
YoY Change -157.16% 125.93%
NET CHANGE
Cash From Operating Activities $69.31M $75.15M
Cash From Investing Activities -$1.323M -$2.553M
Cash From Financing Activities $63.65M -$111.4M
Net Change In Cash $131.3M -$36.82M
YoY Change -456.67% -2535.12%
FREE CASH FLOW
Cash From Operating Activities $69.31M $75.15M
Capital Expenditures $1.500M $2.553M
Free Cash Flow $67.81M $72.60M
YoY Change -6.61% 42.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001295947
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Entity File Number
EntityFileNumber
001-32433
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
PRESTIGE CONSUMER HEALTHCARE INC.
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1297589
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
660 White Plains Road
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591
CY2021Q2 dei City Area Code
CityAreaCode
914
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
524-6800
CY2021Q2 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2021Q2 dei Trading Symbol
TradingSymbol
PBH
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50059989 shares
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
269181000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229394000 USD
CY2021Q2 pbh Cost Of Sales Exclusive Of Depreciation
CostOfSalesExclusiveOfDepreciation
108335000 USD
CY2020Q2 pbh Cost Of Sales Exclusive Of Depreciation
CostOfSalesExclusiveOfDepreciation
94124000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
1834000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
1402000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
110169000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
95526000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
159012000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
133868000 USD
CY2021Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
39439000 USD
CY2020Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
27750000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22471000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19934000 USD
CY2021Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
5760000 USD
CY2020Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
6065000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
67670000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
53749000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
91342000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
80119000 USD
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-15077000 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21941000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
105000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10000 USD
CY2021Q2 pbh Total Other Income Expense
TotalOtherIncomeExpense
-14972000 USD
CY2020Q2 pbh Total Other Income Expense
TotalOtherIncomeExpense
-21951000 USD
CY2021Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
76370000 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
58168000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18615000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14462000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
57755000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
43706000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50139000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50264000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50671000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50808000 shares
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1492000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
10590000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
520000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
309000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-972000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10899000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
56783000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
54605000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
163624000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32302000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14659000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
16457000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130346000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
114671000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
105546000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
114959000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9008000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7903000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
408524000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
269835000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69825000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70059000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22345000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23722000 USD
CY2021Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
8344000 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
8986000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
577840000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
578079000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2469714000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2475729000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2522000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2863000 USD
CY2021Q2 us-gaap Assets
Assets
3559114000 USD
CY2021Q1 us-gaap Assets
Assets
3429273000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
30963000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
45978000 USD
CY2021Q2 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
17067000 USD
CY2021Q1 us-gaap Interest And Dividends Payable Current
InterestAndDividendsPayableCurrent
6312000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5974000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5858000 USD
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2607000 USD
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2588000 USD
CY2021Q2 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
68435000 USD
CY2021Q1 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
61402000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
125046000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
122138000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1545352000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1479653000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
439428000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
434050000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18329000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19706000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8555000 USD
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
6157000 USD
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
6816000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8612000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
2142867000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
2070975000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54211000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53999000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
542000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
540000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
503588000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
499508000 USD
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
4151000 shares
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
4088000 shares
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
133648000 USD
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
130732000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20773000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19801000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1066538000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1008783000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1416247000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1358298000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3559114000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3429273000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1358298000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1878000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2204000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2916000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
57755000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-972000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1416247000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1170971000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1464000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1216000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1242000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
43706000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10899000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1227014000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
57755000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
43706000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7594000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7467000 USD
CY2021Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-26000 USD
CY2020Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-42000 USD
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5876000 USD
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6147000 USD
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
759000 USD
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1400000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1878000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1464000 USD
CY2021Q2 pbh Additions To Operating Lease Right Of Use Assets
AdditionsToOperatingLeaseRightOfUseAssets
1691000 USD
CY2020Q2 pbh Additions To Operating Lease Right Of Use Assets
AdditionsToOperatingLeaseRightOfUseAssets
1831000 USD
CY2021Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
CY2020Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
50000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15879000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-39734000 USD
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9384000 USD
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-51000 USD
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1049000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4019000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18439000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15551000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-32386000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
11588000 USD
CY2021Q2 pbh Increase Decrease In Operating Leases Liabilities
IncreaseDecreaseInOperatingLeasesLiabilities
-1578000 USD
CY2020Q2 pbh Increase Decrease In Operating Leases Liabilities
IncreaseDecreaseInOperatingLeasesLiabilities
-1812000 USD
CY2021Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
40000 USD
CY2020Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
109000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
69305000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
75154000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1500000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2553000 USD
CY2021Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-177000 USD
CY2020Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1323000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2553000 USD
CY2021Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
20000000 USD
CY2020Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
56000000 USD
CY2021Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
85000000 USD
CY2020Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2021Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2020Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
55000000 USD
CY2021Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
638000 USD
CY2020Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
336000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2204000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1216000 USD
CY2021Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2916000 USD
CY2020Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1242000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
63650000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-111362000 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-310000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1942000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
131322000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36819000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32302000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94760000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
163624000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57941000 USD
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
3389000 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
5571000 USD
CY2021Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
2388000 USD
CY2020Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
2182000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
95740000 USD
CY2021Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.  Although these estimates are </span></div>based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. Our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, and accounting for income taxes and related uncertain tax positions.
CY2021Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
9480000 USD
CY2021Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
8463000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
326000 USD
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
326000 USD
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
106170000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
105546000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
114959000 USD
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6000000.0 USD
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4000000.0 USD
CY2021Q1 us-gaap Goodwill Gross
GoodwillGross
743037000 USD
CY2021Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
164958000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
578079000 USD
CY2021Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-239000 USD
CY2021Q2 us-gaap Goodwill Gross
GoodwillGross
742798000 USD
CY2021Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
164958000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
577840000 USD
CY2021Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2671335000 USD
CY2021Q2 pbh Intangible Assets Translation Adjustments Gain Loss
IntangibleAssetsTranslationAdjustmentsGainLoss
-1167000 USD
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2670168000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
195606000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4867000 USD
CY2021Q2 pbh Finite Lived Intangible Assets Accumulated Amortization Translation Adjustments Gain Loss
FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustmentsGainLoss
19000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
200454000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2469714000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4900000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4900000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
14599000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
19465000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
19441000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
17398000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
15126000 USD
CY2021Q2 pbh Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
102840000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
188869000 USD
CY2021Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
642000 USD
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
325000 USD
CY2021Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
66000 USD
CY2020Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
50000 USD
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1687000 USD
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1697000 USD
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
22000 USD
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23000 USD
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
11651000 USD
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
11707000 USD
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
0 USD
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
54000 USD
CY2021Q2 us-gaap Lease Cost
LeaseCost
14068000 USD
CY2020Q2 us-gaap Lease Cost
LeaseCost
13748000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5453000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
2119000 USD
CY2021Q2 pbh Operating And Finance Lease Liability Payments Remainder Of Fiscal Year
OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
7572000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6377000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
2826000 USD
CY2021Q2 pbh Operating And Finance Lease Liability Payments Due Year One
OperatingAndFinanceLeaseLiabilityPaymentsDueYearOne
9203000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6335000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
2826000 USD
CY2021Q2 pbh Operating And Finance Lease Liability Payments Due Year Two
OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo
9161000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4137000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1413000 USD
CY2021Q2 pbh Operating And Finance Lease Liability Payments Due Year Three
OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree
5550000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1815000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 USD
CY2021Q2 pbh Operating And Finance Lease Liability Payments Due Year Four
OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour
1815000 USD
CY2021Q2 pbh Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
3164000 USD
CY2021Q2 pbh Finance Lease Liability To Be Paid Due After Year Four
FinanceLeaseLiabilityToBePaidDueAfterYearFour
0 USD
CY2021Q2 pbh Operating And Finance Lease Liability Payments Due After Year Four
OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour
3164000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
27281000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
9184000 USD
CY2021Q2 pbh Operating And Finance Lease Liability Payment Due
OperatingAndFinanceLeaseLiabilityPaymentDue
36465000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2978000 USD
CY2021Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
420000 USD
CY2021Q2 pbh Operating And Finance Lease Liability Undiscounted Excess Amount
OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
3398000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
24303000 USD
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
8764000 USD
CY2021Q2 pbh Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
33067000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y5M12D
CY2021Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y3M
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0526
CY2021Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0298
CY2021Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
38885000 USD
CY2021Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
29955000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7107000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14074000 USD
CY2021Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
749000 USD
CY2021Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1023000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7772000 USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1652000 USD
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4523000 USD
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4472000 USD
CY2021Q2 pbh Accrued Production Costs Current
AccruedProductionCostsCurrent
3415000 USD
CY2021Q1 pbh Accrued Production Costs Current
AccruedProductionCostsCurrent
2882000 USD
CY2021Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1692000 USD
CY2021Q1 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
2368000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4292000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4976000 USD
CY2021Q2 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
68435000 USD
CY2021Q1 pbh Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
61402000 USD
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1560000000 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1495000000 USD
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
14648000 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
15347000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
1545352000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
1479653000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
475000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
85000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2021Q2 pbh Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1000000000 USD
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1560000000 USD
CY2020Q1 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
2 agreement
CY2021Q1 pbh Derivative Number Of Instruments Settled
DerivativeNumberOfInstrumentsSettled
1 agreement
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000.0 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 pbh Voting Rights Number Of Votes Per Common Share Owned
VotingRightsNumberOfVotesPerCommonShareOwned
1 vote
CY2021Q2 us-gaap Dividends Common Stock
DividendsCommonStock
0 USD
CY2021 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 USD
CY2021Q2 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
57755000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
43706000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50139000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50264000 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
532000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
544000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50671000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50808000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
1000000.0 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
2500000 shares
CY2014Q2 pbh Share Based Compensation Arrangement By Share Based Payment Award Extension Of Expiration Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardExtensionOfExpirationPeriod
P10Y
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1878000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1464000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
143000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
112000 USD
CY2021Q2 pbh Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
7006000 USD
CY2020Q2 pbh Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue
5781000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2204000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1216000 USD
CY2021Q2 pbh Effective Income Tax Rate Reconciliation Deduction Restricted Stock Issuances And Stock Options Amount
EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
1721000 USD
CY2020Q2 pbh Effective Income Tax Rate Reconciliation Deduction Restricted Stock Issuances And Stock Options Amount
EffectiveIncomeTaxRateReconciliationDeductionRestrictedStockIssuancesAndStockOptionsAmount
944000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
13100000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2500000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1020200 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.90
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
249900 shares
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
39.98
CY2020Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
60500 shares
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
20.10
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1209600 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.53
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5770000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
701500 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
39.36
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M24D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3874000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1114900 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.92
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
32.49
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
17600 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
46.09
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
222700 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
44.33
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67900 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1252100 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
39.24
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17068000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
779500 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
38.72
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M6D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11399000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1100000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.249
CY2021Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
278000 USD
CY2020Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
525000 USD
CY2021Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
290000 USD
CY2020Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
647000 USD
CY2021Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-12000 USD
CY2020Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-122000 USD
CY2021Q2 pbh Number Of Third Party Manufacturers
NumberOfThirdPartyManufacturers
118 manufacturer
CY2020Q2 pbh Number Of Third Party Manufacturers
NumberOfThirdPartyManufacturers
113 manufacturer
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
269181000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
110169000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
159012000 USD
CY2021Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
39439000 USD
CY2021Q2 pbh Contribution Margin
ContributionMargin
119573000 USD
CY2021Q2 pbh General And Administrative And Depreciation And Amortization Expense
GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
28231000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
91342000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229394000 USD
CY2020Q2 pbh General And Administrative And Depreciation And Amortization Expense
GeneralAndAdministrativeAndDepreciationAndAmortizationExpense
25999000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
80119000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
95526000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
133868000 USD
CY2020Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
27750000 USD
CY2020Q2 pbh Contribution Margin
ContributionMargin
106118000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
269181000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229394000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
269181000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
229394000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
577840000 USD
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2280845000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
188869000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2469714000 USD
CY2021Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3047554000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
578079000 USD
CY2021Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2281988000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
193741000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2475729000 USD
CY2021Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3053808000 USD

Files In Submission

Name View Source Status
0001295947-21-000029-index-headers.html Edgar Link pending
0001295947-21-000029-index.html Edgar Link pending
0001295947-21-000029.txt Edgar Link pending
0001295947-21-000029-xbrl.zip Edgar Link pending
exhibit21apa.htm Edgar Link pending
exhibit21apa001.jpg Edgar Link pending
exhibit21apa002.jpg Edgar Link pending
exhibit21apa003.jpg Edgar Link pending
exhibit21apa004.jpg Edgar Link pending
exhibit21apa005.jpg Edgar Link pending
exhibit21apa006.jpg Edgar Link pending
exhibit21apa007.jpg Edgar Link pending
exhibit21apa008.jpg Edgar Link pending
exhibit21apa009.jpg Edgar Link pending
exhibit21apa010.jpg Edgar Link pending
exhibit21apa011.jpg Edgar Link pending
exhibit21apa012.jpg Edgar Link pending
exhibit21apa013.jpg Edgar Link pending
exhibit21apa014.jpg Edgar Link pending
exhibit21apa015.jpg Edgar Link pending
exhibit21apa016.jpg Edgar Link pending
exhibit21apa017.jpg Edgar Link pending
exhibit21apa018.jpg Edgar Link pending
exhibit21apa019.jpg Edgar Link pending
exhibit21apa020.jpg Edgar Link pending
exhibit21apa021.jpg Edgar Link pending
exhibit21apa022.jpg Edgar Link pending
exhibit21apa023.jpg Edgar Link pending
exhibit21apa024.jpg Edgar Link pending
exhibit21apa025.jpg Edgar Link pending
exhibit21apa026.jpg Edgar Link pending
exhibit21apa027.jpg Edgar Link pending
exhibit21apa028.jpg Edgar Link pending
exhibit21apa029.jpg Edgar Link pending
exhibit21apa030.jpg Edgar Link pending
exhibit21apa031.jpg Edgar Link pending
exhibit21apa032.jpg Edgar Link pending
exhibit21apa033.jpg Edgar Link pending
exhibit21apa034.jpg Edgar Link pending
exhibit21apa035.jpg Edgar Link pending
exhibit21apa036.jpg Edgar Link pending
exhibit21apa037.jpg Edgar Link pending
exhibit21apa038.jpg Edgar Link pending
exhibit21apa039.jpg Edgar Link pending
exhibit21apa040.jpg Edgar Link pending
exhibit21apa041.jpg Edgar Link pending
exhibit21apa042.jpg Edgar Link pending
exhibit21apa043.jpg Edgar Link pending
exhibit21apa044.jpg Edgar Link pending
exhibit21apa045.jpg Edgar Link pending
exhibit21apa046.jpg Edgar Link pending
exhibit21apa047.jpg Edgar Link pending
exhibit21apa048.jpg Edgar Link pending
exhibit21apa049.jpg Edgar Link pending
exhibit21apa050.jpg Edgar Link pending
exhibit21apa051.jpg Edgar Link pending
exhibit21apa052.jpg Edgar Link pending
exhibit21apa053.jpg Edgar Link pending
exhibit21apa054.jpg Edgar Link pending
exhibit21apa055.jpg Edgar Link pending
exhibit21apa056.jpg Edgar Link pending
exhibit21apa057.jpg Edgar Link pending
exhibit21apa058.jpg Edgar Link pending
exhibit21apa059.jpg Edgar Link pending
exhibit21apa060.jpg Edgar Link pending
exhibit21apa061.jpg Edgar Link pending
exhibit21apa062.jpg Edgar Link pending
exhibit21apa063.jpg Edgar Link pending
exhibit21apa064.jpg Edgar Link pending
exhibit21apa065.jpg Edgar Link pending
exhibit3112021-06x30.htm Edgar Link pending
exhibit3122021-06x30.htm Edgar Link pending
exhibit3212021-06x30.htm Edgar Link pending
exhibit3222021-06x30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pbh-20210630.htm Edgar Link pending
pbh-20210630.xsd Edgar Link pending
pbh-20210630_cal.xml Edgar Link unprocessable
pbh-20210630_def.xml Edgar Link unprocessable
pbh-20210630_g1.jpg Edgar Link pending
pbh-20210630_htm.xml Edgar Link completed
pbh-20210630_lab.xml Edgar Link unprocessable
pbh-20210630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending